|
OPK | Opko Health, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 1.60 |
| Leverage | 34.37% |
| Market Cap | $ 791.1m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -225.4m |
| Margin | -39.09% |
OPKO Health, Inc., a healthcare company, is engaged in the pharmaceutical and diagnostic businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company is headquartered in Miami, Florida.